Journal
ANTIVIRAL RESEARCH
Volume 128, Issue -, Pages 7-19Publisher
ELSEVIER
DOI: 10.1016/j.antiviral.2016.01.002
Keywords
Flavivirus; Dengue virus; Antibody; Neutralization mechanism; Therapeutic antibodies
Categories
Funding
- Singapore Ministry of Education Tier 3 grant [MOE2012-T3-1-008]
Ask authors/readers for more resources
Dengue virus, a positive-sense RNA virus, is one of the major human pathogens transmitted by mosquitoes. However, no fully effective licensed dengue vaccines or therapeutics are currently available. Several potent neutralizing antibodies against DENV have been isolated from Mice and humans, and the characterization of their properties by biochemical and biophysical methods have revealed important insights for development of therapeutic antibodies. In this review, we summarize recently reported antibody antigen-complex structures, their likely neutralization mechanisms and enhancement propensities, as well as their prophylactic and therapeutic capabilities in mouse models. This article forms part of a symposium on flavivirus drug discovery in the journal Antiviral Research. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available